Chronic Inflammation: The Therapeutic Potential of Beta-Caryophyllene
About the webinar
Learning Outcomes
- Understand how beta-caryophyllene interacts with the endocannabinoid system, particularly its affinity for CB2 receptors and its anti-inflammatory pathways.
- Recognise the presence of beta-caryophyllene in various cannabis strains and understand how it works synergistically with cannabinoids like THC and CBD to enhance therapeutic outcomes.
- Summarise key findings from preclinical and clinical research on the anti-inflammatory effects of beta-caryophyllene, and determine appropriate dosage and administration methods for treating conditions associated with chronic inflammation.
- Identify the potential benefits of beta-caryophyllene for specific conditions such as arthritis, IBS, and neuroinflammation, and discuss safety considerations and potential side effects.
About the speaker

Claim 1 CPD Hour

Related content
On-demand WebinarPastilles in Clinical Practice: Optimising Precision Dosing, Adherence and Patient Outcomes
Explore the clinical role of cannabis pastilles, including precision dosing, patient selection, adherence, safety and the evolving evidence for major and minor cannabinoids.
Learn more
Live Webinar02 Dec 2026, 07:00 PMBeyond the Dose: Understanding Oral Cannabinoid Therapy
Explore how formulation, absorption and metabolism influence the bioavailability and clinical effects of oral THC and CBD. This webinar examines key pharmacokinetic principles, emerging delivery technologies and published evidence to inform formulation selection, dosing and patient monitoring.
Learn more
On-demand WebinarEmerging Therapeutics for Behavioural and Psychological Symptoms of Dementia
Explore evidence-based management of behavioural and psychological symptoms of dementia and the emerging role of cannabinoid-based medicines.
Learn more
On-demand WebinarTHCV and Metabolic Health: Exploring the Evidence and Clinical Potential
Explore the emerging role of Δ9-tetrahydrocannabivarin (THCV) in metabolic health, including its potential influence on appetite regulation, glucose metabolism and weight management. This session reviews THCV pharmacology, CB1 signalling, current preclinical and human evidence, and the key limitations shaping its potential future clinical application.
Learn more

.png)

.png)